NEW YORK ( TheStreet) -- Conceptus (Nasdaq: CPTS) hit a new 52-week low Monday as it is currently trading at $12.05, below its previous 52-week high of $17.74 with 21,249 shares traded as of 10:15 a.m. ET. Average volume has been 248,700 shares over the past 30 days.

Conceptus has a market cap of $387.4 million and is part of the health care sector and health services industry. Shares are down 11.1% year to date as of the close of trading on Friday.

Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications. It offers Essure, a permanent birth control system for women. The company has a P/E ratio of 4.8, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
  • Practice your CPTS trading strategies and win cash in our stock game.

TheStreet Ratings rates Conceptus as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. You can view the full Conceptus Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

If you liked this article you might like

Conceptus Inc. Stock Downgraded (CPTS)

Stock Futures Rising Ahead of U.S. Home Sales Report

Morning Briefing: 10 Things You Should Know

Conceptus Inc. Stock Upgraded (CPTS)

4 Stocks Spiking on Unusual Volume